Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$5,623,911
+$19,636 QoQ
Shares Held
22,144
-3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.32%
of 13F equity value
Holder Rank
#1,537
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADVISORS MANAGEMENT GROUP INC /ADV holds $7,828,853 across 8 Drug Manufacturers - General names. JNJ ranks #1 (71.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
22,144 | $5,623,911 | |
| 2 | AZN |
Astrazeneca PLC
|
2,355 | $446,555 | |
| 3 | NVS |
Novartis AG
|
2,167 | $339,612 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,579 | $331,401 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
5,643 | $325,149 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,521 | $318,503 | |
| 7 | GSK |
GSK plc
|
4,634 | $242,914 | |
| 8 | ABBV |
AbbVie Inc.
|
798 | $200,808 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,623,911 | 22,144 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $5,604,275 | 22,927 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $5,476,103 | 26,461 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $5,481,200 | 29,561 | Shares | Sole | 2025-12-18 | |
| 2025-06-30 | $4,403,018 | 28,825 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $4,826,939 | 29,106 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $4,193,401 | 28,996 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $4,721,618 | 29,135 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $4,261,587 | 29,157 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $4,614,718 | 29,172 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $4,598,594 | 29,339 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $4,591,665 | 29,481 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $4,867,943 | 29,410 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $4,619,000 | 29,800 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $5,263,110 | 29,794 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $4,897,042 | 29,977 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $4,932,292 | 27,786 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $4,909,271 | 27,700 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $4,753,693 | 27,788 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $4,528,944 | 28,043 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $4,659,670 | 28,285 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $4,689,891 | 28,536 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $4,514,287 | 28,684 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $4,269,282 | 28,676 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $4,054,081 | 28,828 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $3,873,186 | 29,537 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||